REVIEW 00 // THYMOSIN ALPHA-1 STUDIES
Studies of Thymosin alpha-1 found mixed results in hepatitis, sepsis, cancer and severe COVID-19.
You can read the strongest finding first, then its limits.
Thymosin alpha-1 showed promise, but the proof varies
Researchers first found Thymosin alpha-1 in a calf’s thymus gland. In 1977, they mapped its twenty-eight linked protein parts [1]. Thymalfasin is the man-made drug.
It’s approved in 30+ countries for hepatitis B and C. Those are long-lasting liver infections. A 2020 review brought the main studies together [2].
A lab scale puts the drug’s weight at 3,108 daltons. A dalton is a tiny unit used for molecules. That weight doesn’t tell you whether the drug will help.
The papers number two immune-cell message spots 9 and 2 [4][5]. Those numbers are only lab labels. Each spot can alert your defenses, much like a doorbell.
The strongest results came from several serious illnesses. A 2008 review found better lasting virus control in hepatitis B [12]. A 2013 sepsis study saw fewer deaths after 28-day care.
People got 1.6 mg in a skin shot [6]. A 2015 review also found fewer deaths after joining several studies [7]. A 2020 study of severe COVID-19 followed 76 people.
At the 28-day mark, deaths fell from 30.0% to 11.1%. Blood tests found more immune cells ready to work [8]. You can read the result beside your health, but it can’t predict your outcome.
Thymosin alpha-1 changed cells in dishes and mice
Thymosin alpha-1 is a small protein with 28 parts linked together. Each part is one building block of protein. The natural form comes from a larger protein [1]. Its make-up can’t tell you what Thymosin alpha-1 will do.
The papers studied cell message spots numbered 9 and 2. Those numbers are lab labels, not doses or results. Thymosin alpha-1 used the spots to alert immune guide cells [4][5].
A 2006 study of cells in dishes found both support and calm [4]. A 2007 study found a stronger virus defense in mice [5]. Mice aren’t people, so you can’t use Thymosin alpha-1 results in mice to predict your body or your benefit.
TA1 peptide and thymalfasin mean the same drug
<a id="synonyms"></a>You may see four names for the same small protein. A short protein is also called a peptide. The drug has twenty-eight linked parts.
The names are TA1 peptide, Tα1, thymalfasin and Zadaxin. Thymosin alpha-1 became its name after the 1977 discovery [1]. Papers from the 2000s often use Tα1 or the other short form.
Thymalfasin is the common drug name for the man-made form [20]. Zadaxin is its brand name in 30+ countries. One name doesn’t mean you’ve found a different drug.
The studies here used a man-made copy of the natural protein. That copy matches the one first found in calf thymus fraction 5. For you, the key is that a new name doesn’t give you a new drug for your body.
Six uses lead the Thymosin Alpha-1 research
A 2020 review joined the best-known Thymosin alpha-1 studies [2]. It covered hepatitis B and C, severe sepsis and COVID-19. It also covered cancer care, flu shots and care after a transplant. Start with the illness that concerns you.
The hepatitis B and C studies explain approval in some countries. A 2013 sepsis study in critical care followed very sick people [6]. Later work includes a 2020 Wuhan COVID study [8] and a 2023 long-COVID study [11].
A 2020 lung-cancer paper leads the cancer research [15]. You can also read about Thymosin alpha-1 benefits and Thymosin alpha-1 dosage. The common questions page gives shorter answers.
Thymosin alpha-1 is a small natural protein
The natural form is a protein with twenty-eight linked parts. Researchers first found it in calf thymus fraction 5. Goldstein and his team published its make-up in 1977 [1].
Thymalfasin is the man-made copy. You may see its brand in 30+ countries for hepatitis B and C [20]. Thymosin beta-4, also called TB-500, is a different protein. If you mix up the names, you’ll also misread the results that matter to your choice.
Thymosin alpha-1 may wake defenses or calm them
The papers number two cell message spots 9 and 2 [4][5]. Another cell message carries the number 2. Those numbers are only lab labels.
The drug used those paths to help infection-fighting cells grow and act. A 2006 study found signs of both support and calm. A 2007 study found a stronger virus response in mice [4][5]. Mice aren’t people, so you can’t use that result to predict your body or your benefit.
Researchers studied it in several serious illnesses
Researchers studied Thymosin alpha-1 in hepatitis B and C. The drug is approved for them in 30+ countries [12][13][14]. They also studied severe sepsis, when infection harms the whole body [6][7].
Severe COVID-19 studies include work from 2023 [8][9][22][23]. Other work covers lung cancer [15][16], flu shots [18] and partly matched transplants [19]. This list helps you find your illness, but it can’t choose your care.
The list can’t tell you what fits your health or what you may face. The FDA also reviewed use by pharmacies that mix medicine for one person [21]. That review didn’t approve the drug. It can’t tell you whether the drug is safe for you or right for your health.